Gene · 2887
Papers1,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine. | Int J Mol Sci | 2023 | 37628728 | PubTator, text mining | PubMed |
| Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits. | Nat Commun | 2023 | 37604891 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. | Mol Cancer | 2023 | 37596643 | PubTator, text mining | PubMed |
| Regulation of CD8+ T memory and exhaustion by the mTOR signals. | Cell Mol Immunol | 2023 | 37582972 | PubTator, text mining | PubMed |
| Five Critical Gene-Based Biomarkers With Optimal Performance for Hepatocellular Carcinoma. | Cancer Inform | 2023 | 37577174 | PubTator, text mining | PubMed |
| TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach. | PLoS One | 2023 | 37535601 | PubTator, text mining | PubMed |
| Case report: atypical Silver-Russell syndrome patient with hand dystonia: the valuable support of the consensus statement to the wide syndromic spectrum. | Front Genet | 2023 | 37529781 | PubTator, text mining | PubMed |
| Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer. | Pharmaceuticals (Basel) | 2023 | 37513916 | PubTator, text mining | PubMed |
| The Molecular and Genetic Interactions between Obesity and Breast Cancer Risk. | Medicina (Kaunas) | 2023 | 37512149 | PubTator, text mining | PubMed |
| Personalized Medicine in Medullary Thyroid Carcinoma: A Broad Review of Emerging Treatments. | J Pers Med | 2023 | 37511745 | PubTator, text mining | PubMed |
| mTOR Signaling Pathway and Gut Microbiota in Various Disorders: Mechanisms and Potential Drugs in Pharmacotherapy. | Int J Mol Sci | 2023 | 37511569 | PubTator, text mining | PubMed |
| Regulation of mTOR Signaling: Emerging Role of Cyclic Nucleotide-Dependent Protein Kinases and Implications for Cardiometabolic Disease. | Int J Mol Sci | 2023 | 37511253 | PubTator, text mining | PubMed |
| mTOR inhibition reprograms cellular proteostasis by regulating eIF3D-mediated selective mRNA translation and promotes cell phenotype switching. | Cell Rep | 2023 | 37494188 | PubTator, text mining | PubMed |
| Low Expression of GIGYF1 Inhibits Metastasis, Proliferation, and Promotes Apoptosis and Autophagy of Gastric Cancer Cells. | Int J Med Sci | 2023 | 37484805 | PubTator, text mining | PubMed |
| Expression of mTOR in normal and pathological conditions. | Mol Cancer | 2023 | 37454139 | PubTator, text mining | PubMed |
| Cryopreservation of Ovarian and Testicular Tissue and the Influence on Epigenetic Pattern. | Int J Mol Sci | 2023 | 37446239 | PubTator, text mining | PubMed |
MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology. | Viruses | 2023 | 37376663 | PubTator, text mining | PubMed |
| DNA methylation partially mediates antidiabetic effects of metformin on HbA1c levels in individuals with type 2 diabetes. | Diabetes Res Clin Pract | 2023 | 37356726 | PubTator, text mining | PubMed |
| The Phosphorylation of Kv1.3: A Modulatory Mechanism for a Multifunctional Ion Channel. | Cancers (Basel) | 2023 | 37345053 | PubTator, text mining | PubMed |
| mTOR Signaling Pathway in Bone Diseases Associated with Hyperglycemia. | Int J Mol Sci | 2023 | 37298150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2887/papers?page=5